By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted July 25, 2024APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON AUGUST 8, 2024 READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted May 9, 2024APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS; REAFFIRMS FULL YEAR 2024 FINANCIAL OUTLOOK READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted May 9, 2024APYX MEDICAL CORPORATION ANNOUNCES BOARD LEADERSHIP TRANSITION READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted April 25, 2024APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON MAY 9, 2024 READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted March 21, 2024APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted March 4, 2024APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON MARCH 21, 2024 READ MORE
By apyxmedical In 2024 Shareholder News, J-Plasma, RenuvionPosted January 22, 2024APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted January 8, 2024APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2023 REVENUE RESULTS READ MORE
By Nick Johnson (Apyx) In 2023 Shareholder News, J-Plasma, RenuvionPosted November 28, 2023APYX MEDICAL CORPORATION APPOINTS MATTHEW HILL AS CHIEF FINANCIAL OFFICER READ MORE
By Nick Johnson (Apyx) In 2023 Shareholder News, J-Plasma, RenuvionPosted November 9, 2023APYX MEDICAL CORPORATION ANNOUNCES NEW DEBT FACILITY WITH PERCEPTIVE ADVISORS READ MORE
